Search results
Results From The WOW.Com Content Network
Exact Sciences Corp. is a molecular diagnostics company based in Madison, Wisconsin specializing in the detection of early stage cancers. The company's initial focus was on the early detection and prevention of colorectal cancer; in 2014 it launched Cologuard, the first stool DNA test for colorectal cancer. Since then Exact Sciences has grown ...
We continue to expect full year revenue between $2.81 billion and $2.85 billion, and now expect adjusted EBITDA between $335 million and $355 million or 12.2% margin rate at midpoint. During the ...
The exact sciences or quantitative sciences, sometimes called the exact mathematical sciences, [1] are those sciences "which admit of absolute precision in their results"; especially the mathematical sciences. [2] Examples of the exact sciences are mathematics, optics, astronomy, [3] and physics, which many philosophers from Descartes, Leibniz ...
Hard science and soft science are colloquial terms used to compare scientific fields on the basis of perceived methodological rigor, exactitude, and objectivity. [1] [2] [3] In general, the formal sciences and natural sciences are considered hard science, whereas the social sciences and other sciences are described as soft science. [4]
Exact Sciences Reports Fourth-Quarter 2012 Financial Results MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (NAS: EXAS) today announced its financial results for the quarter and year ended ...
Exact Sciences to Host Second-Quarter 2013 Results, Annual Meeting Webcasts and Calls MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (NAS: EXAS) today announced that the company will host ...
Descriptive research is mainly done when a researcher wants to gain a better understanding of a topic. That is, analysis of the past as opposed to the future. Descriptive research is the exploration of the existing certain phenomena. The details of the facts won't be known. The existing phenomena's facts are not known to the person.
The company said it plans to complete submission of its marketing application for the new test to the U.S. Food and Drug Administration (FDA) by the end of this year. The company reported $1.43 ...